版本:
中国

BRIEF-Endocyte form 4 discloses CEO's 44,285 stock options fully vested on May 31, immediately exercisable

June 2 Endocyte Inc

* Endocyte Inc form 4 discloses that CEO Michael Sherman's 44,285 stock options (right to buy) fully vested on may 31 and immediately exercisable - sec filing Source text (bit.ly/2rytsCJ) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐